Trinity Biotech | TRIB - Debt


Trinity Biotech reported $100.76M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bio-Rad Laboratories USD 1.4B 11.2M Sep/2025
EDAP TMS EUR 7.55M 1.41M Sep/2025
J&J USD 47.93B 2.14B Dec/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
OraSure Technologies USD 782K 465K Jun/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 56.02B 673M Sep/2025
Surmodics USD 29.55M 111K Sep/2024
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Tosoh JPY 172.31B 6.79B Sep/2025
Trinity Biotech USD 100.76M 7.05M Dec/2024
Veracyte USD 40.45M 10.19M Sep/2025